| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 1.23e-09 | 37 | 60 | 6 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 1.46e-09 | 38 | 60 | 6 | GO:0070001 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 4.24e-07 | 21 | 60 | 4 | GO:0035613 | |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 4.18e-06 | 11 | 60 | 3 | GO:0004523 | |
| GeneOntologyMolecularFunction | steroid 11-beta-monooxygenase activity | 8.88e-06 | 2 | 60 | 2 | GO:0004507 | |
| GeneOntologyMolecularFunction | corticosterone 18-monooxygenase activity | 8.88e-06 | 2 | 60 | 2 | GO:0047783 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 9.17e-06 | 14 | 60 | 3 | GO:0003964 | |
| GeneOntologyMolecularFunction | steroid hydroxylase activity | 1.44e-04 | 34 | 60 | 3 | GO:0008395 | |
| GeneOntologyMolecularFunction | transition metal ion binding | ERVK-6 ZSWIM8 TRAF4 CYP2R1 ENPP1 CYP11B1 CYP11B2 EGLN1 ERVK-8 ERVK-19 ERVK-7 D2HGDH | 1.84e-04 | 1189 | 60 | 12 | GO:0046914 |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 1.86e-04 | 37 | 60 | 3 | GO:0016891 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 2.02e-04 | 38 | 60 | 3 | GO:0034061 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 3.57e-04 | 46 | 60 | 3 | GO:0016893 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen | 6.78e-04 | 13 | 60 | 2 | GO:0016713 | |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase regulatory subunit binding | 7.89e-04 | 14 | 60 | 2 | GO:0036312 | |
| GeneOntologyMolecularFunction | iron ion binding | 1.56e-03 | 166 | 60 | 4 | GO:0005506 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 1.73e-03 | 79 | 60 | 3 | GO:0004521 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 1.81e-03 | 430 | 60 | 6 | GO:0004175 | |
| GeneOntologyMolecularFunction | ubiquitin-like ligase-substrate adaptor activity | 1.93e-03 | 82 | 60 | 3 | GO:1990756 | |
| GeneOntologyMolecularFunction | 3',5'-cyclic-AMP phosphodiesterase activity | 1.97e-03 | 22 | 60 | 2 | GO:0004115 | |
| GeneOntologyMolecularFunction | 3',5'-cyclic-nucleotide phosphodiesterase activity | 2.55e-03 | 25 | 60 | 2 | GO:0004114 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ester bonds | 2.74e-03 | 807 | 60 | 8 | GO:0016788 | |
| GeneOntologyMolecularFunction | K63-linked polyubiquitin modification-dependent protein binding | 2.75e-03 | 26 | 60 | 2 | GO:0070530 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 2.76e-03 | 194 | 60 | 4 | GO:0016705 | |
| GeneOntologyMolecularFunction | enzyme-substrate adaptor activity | 2.93e-03 | 95 | 60 | 3 | GO:0140767 | |
| GeneOntologyMolecularFunction | cyclic-nucleotide phosphodiesterase activity | 2.97e-03 | 27 | 60 | 2 | GO:0004112 | |
| GeneOntologyMolecularFunction | phosphoric diester hydrolase activity | 3.11e-03 | 97 | 60 | 3 | GO:0008081 | |
| GeneOntologyMolecularFunction | peptidase activity | 3.36e-03 | 654 | 60 | 7 | GO:0008233 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | 4.08e-03 | 507 | 60 | 6 | GO:0060589 | |
| GeneOntologyMolecularFunction | GTPase regulator activity | 4.08e-03 | 507 | 60 | 6 | GO:0030695 | |
| GeneOntologyMolecularFunction | zinc ion binding | 4.99e-03 | 891 | 60 | 8 | GO:0008270 | |
| GeneOntologyMolecularFunction | monooxygenase activity | 5.02e-03 | 115 | 60 | 3 | GO:0004497 | |
| GeneOntologyMolecularFunction | nuclease activity | 5.13e-03 | 231 | 60 | 4 | GO:0004518 | |
| GeneOntologyMolecularFunction | phosphoric ester hydrolase activity | 6.01e-03 | 386 | 60 | 5 | GO:0042578 | |
| GeneOntologyMolecularFunction | 14-3-3 protein binding | 7.08e-03 | 42 | 60 | 2 | GO:0071889 | |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase binding | 7.41e-03 | 43 | 60 | 2 | GO:0043548 | |
| GeneOntologyMolecularFunction | steroid binding | 7.50e-03 | 133 | 60 | 3 | GO:0005496 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | 7.97e-03 | 136 | 60 | 3 | GO:0004540 | |
| GeneOntologyMolecularFunction | endonuclease activity | 7.97e-03 | 136 | 60 | 3 | GO:0004519 | |
| GeneOntologyBiologicalProcess | DNA integration | 6.56e-06 | 13 | 60 | 3 | GO:0015074 | |
| GeneOntologyBiologicalProcess | regulation of blood volume by renal aldosterone | 4.97e-05 | 4 | 60 | 2 | GO:0002017 | |
| GeneOntologyCellularComponent | dendrite | 7.15e-04 | 858 | 60 | 9 | GO:0030425 | |
| GeneOntologyCellularComponent | cleavage furrow | 7.19e-04 | 61 | 60 | 3 | GO:0032154 | |
| GeneOntologyCellularComponent | dendritic tree | 7.27e-04 | 860 | 60 | 9 | GO:0097447 | |
| GeneOntologyCellularComponent | site of polarized growth | 7.92e-04 | 253 | 60 | 5 | GO:0030427 | |
| GeneOntologyCellularComponent | cell tip | 1.07e-03 | 17 | 60 | 2 | GO:0051286 | |
| GeneOntologyCellularComponent | cell body | 1.25e-03 | 929 | 60 | 9 | GO:0044297 | |
| GeneOntologyCellularComponent | cell pole | 1.49e-03 | 20 | 60 | 2 | GO:0060187 | |
| GeneOntologyCellularComponent | cell division site | 1.58e-03 | 80 | 60 | 3 | GO:0032153 | |
| MousePheno | abnormal urine progesterone level | 9.24e-06 | 2 | 43 | 2 | MP:0011545 | |
| MousePheno | abnormal urine deoxycorticosterone level | 9.24e-06 | 2 | 43 | 2 | MP:0011552 | |
| MousePheno | decreased urine corticosterone level | 9.24e-06 | 2 | 43 | 2 | MP:0011550 | |
| MousePheno | increased urine deoxycorticosterone level | 9.24e-06 | 2 | 43 | 2 | MP:0011553 | |
| MousePheno | increased urine progesterone level | 9.24e-06 | 2 | 43 | 2 | MP:0011546 | |
| MousePheno | abnormal adrenal gland zona glomerulosa morphology | 5.52e-05 | 4 | 43 | 2 | MP:0008293 | |
| MousePheno | decreased urine aldosterone level | 5.52e-05 | 4 | 43 | 2 | MP:0011541 | |
| MousePheno | abnormal urine aldosterone level | 5.52e-05 | 4 | 43 | 2 | MP:0011539 | |
| MousePheno | abnormal urine corticosterone level | 5.52e-05 | 4 | 43 | 2 | MP:0011548 | |
| MousePheno | decreased urine hormone level | 5.52e-05 | 4 | 43 | 2 | MP:0014459 | |
| MousePheno | abnormal cerebral aqueduct morphology | 7.53e-05 | 27 | 43 | 3 | MP:0005537 | |
| MousePheno | increased adrenal gland zona fasciculata size | 9.19e-05 | 5 | 43 | 2 | MP:0014286 | |
| MousePheno | uterus adenomyosis | 1.38e-04 | 6 | 43 | 2 | MP:0009221 | |
| MousePheno | increased urine hormone level | 1.38e-04 | 6 | 43 | 2 | MP:0014458 | |
| MousePheno | adrenal gland hyperplasia | 1.38e-04 | 6 | 43 | 2 | MP:0009078 | |
| MousePheno | abnormal urine hormone level | 1.92e-04 | 7 | 43 | 2 | MP:0011538 | |
| MousePheno | pituitary gland hyperplasia | 1.92e-04 | 7 | 43 | 2 | MP:0000635 | |
| MousePheno | increased circulating angiotensin II level | 2.56e-04 | 8 | 43 | 2 | MP:0031232 | |
| MousePheno | increased angiotensin II level | 2.56e-04 | 8 | 43 | 2 | MP:0031229 | |
| MousePheno | decreased circulating renin level | 4.09e-04 | 10 | 43 | 2 | MP:0003353 | |
| MousePheno | abnormal adrenocortical cell morphology | 4.09e-04 | 10 | 43 | 2 | MP:0008291 | |
| MousePheno | cerebral aqueductal stenosis | 4.09e-04 | 10 | 43 | 2 | MP:0002958 | |
| MousePheno | abnormal adrenal gland zona fasciculata size | 4.99e-04 | 11 | 43 | 2 | MP:0014284 | |
| MousePheno | globular heart | 4.99e-04 | 11 | 43 | 2 | MP:0031511 | |
| MousePheno | uterus cyst | 4.99e-04 | 11 | 43 | 2 | MP:0009082 | |
| MousePheno | increased myocardial fiber size | 5.71e-04 | 53 | 43 | 3 | MP:0004564 | |
| MousePheno | abnormal circulating angiotensin II level | 5.98e-04 | 12 | 43 | 2 | MP:0031230 | |
| MousePheno | abnormal angiotensin II level | 5.98e-04 | 12 | 43 | 2 | MP:0031227 | |
| MousePheno | hypokalemia | 5.98e-04 | 12 | 43 | 2 | MP:0004119 | |
| MousePheno | enlarged pituitary gland | 5.98e-04 | 12 | 43 | 2 | MP:0000636 | |
| MousePheno | abnormal heart size | ZSWIM8 NLRP9 MYH10 ENPP1 CYP11B1 CYP11B2 EGLN1 COBL TSC2 PRAMEF13 MSN | 6.81e-04 | 1180 | 43 | 11 | MP:0005406 |
| MousePheno | increased renin activity | 8.22e-04 | 14 | 43 | 2 | MP:0005582 | |
| MousePheno | decreased circulating mineralocorticoid level | 8.22e-04 | 14 | 43 | 2 | MP:0003374 | |
| MousePheno | increased urine osmolality | 8.22e-04 | 14 | 43 | 2 | MP:0008055 | |
| MousePheno | increased circulating adrenocorticotropin level | 8.22e-04 | 14 | 43 | 2 | MP:0001748 | |
| MousePheno | decreased circulating aldosterone level | 8.22e-04 | 14 | 43 | 2 | MP:0002667 | |
| MousePheno | endometrium hyperplasia | 8.22e-04 | 14 | 43 | 2 | MP:0009092 | |
| MousePheno | obstructive hydrocephaly | 1.08e-03 | 16 | 43 | 2 | MP:0000917 | |
| MousePheno | decreased circulating mineral level | 1.17e-03 | 391 | 43 | 6 | MP:0014548 | |
| Domain | FERM_C | 8.25e-07 | 26 | 53 | 4 | PF09380 | |
| Domain | FERM_C | 9.66e-07 | 27 | 53 | 4 | SM01196 | |
| Domain | FERM_PH-like_C | 9.66e-07 | 27 | 53 | 4 | IPR018980 | |
| Domain | FERM_N | 2.22e-06 | 33 | 53 | 4 | PF09379 | |
| Domain | FERM_N | 2.22e-06 | 33 | 53 | 4 | IPR018979 | |
| Domain | Cyt_P450_mitochondrial | 7.90e-06 | 2 | 53 | 2 | IPR002399 | |
| Domain | FERM_M | 8.63e-06 | 46 | 53 | 4 | PF00373 | |
| Domain | - | 1.11e-05 | 49 | 53 | 4 | 1.20.80.10 | |
| Domain | FERM_central | 1.11e-05 | 49 | 53 | 4 | IPR019748 | |
| Domain | FERM_domain | 1.11e-05 | 49 | 53 | 4 | IPR000299 | |
| Domain | FERM_1 | 1.21e-05 | 50 | 53 | 4 | PS00660 | |
| Domain | FERM_2 | 1.21e-05 | 50 | 53 | 4 | PS00661 | |
| Domain | FERM_3 | 1.21e-05 | 50 | 53 | 4 | PS50057 | |
| Domain | Band_41_domain | 1.21e-05 | 50 | 53 | 4 | IPR019749 | |
| Domain | B41 | 1.21e-05 | 50 | 53 | 4 | SM00295 | |
| Domain | FERM/acyl-CoA-bd_prot_3-hlx | 1.21e-05 | 50 | 53 | 4 | IPR014352 | |
| Domain | Ez/rad/moesin-like | 2.77e-05 | 21 | 53 | 3 | IPR000798 | |
| Domain | FERM_CS | 4.19e-05 | 24 | 53 | 3 | IPR019747 | |
| Domain | ERM_C_dom | 4.72e-05 | 4 | 53 | 2 | IPR011259 | |
| Domain | ERM | 4.72e-05 | 4 | 53 | 2 | PF00769 | |
| Domain | ERM | 4.72e-05 | 4 | 53 | 2 | IPR011174 | |
| Domain | - | 1.12e-04 | 391 | 53 | 7 | 2.30.29.30 | |
| Domain | Moesin_tail | 1.64e-04 | 7 | 53 | 2 | IPR008954 | |
| Domain | Ubiquitin-rel_dom | 1.72e-04 | 184 | 53 | 5 | IPR029071 | |
| Domain | PH_dom-like | 1.91e-04 | 426 | 53 | 7 | IPR011993 | |
| Domain | Cyt_P450_CS | 4.57e-04 | 53 | 53 | 3 | IPR017972 | |
| Domain | CYTOCHROME_P450 | 5.67e-04 | 57 | 53 | 3 | PS00086 | |
| Domain | - | 5.96e-04 | 58 | 53 | 3 | 1.10.630.10 | |
| Domain | p450 | 5.96e-04 | 58 | 53 | 3 | PF00067 | |
| Domain | Cyt_P450 | 6.59e-04 | 60 | 53 | 3 | IPR001128 | |
| Domain | DAPIN | 1.76e-03 | 22 | 53 | 2 | PS50824 | |
| Domain | PYRIN | 1.76e-03 | 22 | 53 | 2 | PF02758 | |
| Domain | DAPIN | 1.76e-03 | 22 | 53 | 2 | IPR004020 | |
| Domain | PYRIN | 1.76e-03 | 22 | 53 | 2 | SM01289 | |
| Domain | NACHT | 1.92e-03 | 23 | 53 | 2 | PS50837 | |
| Domain | NACHT_NTPase | 1.92e-03 | 23 | 53 | 2 | IPR007111 | |
| Domain | Rho_GTPase_activation_prot | 2.00e-03 | 88 | 53 | 3 | IPR008936 | |
| Pathway | KEGG_MEDICUS_REFERENCE_STEROID_HORMONE_BIOSYNTHESIS_PROGESTERONE_TO_CORTISOL_CORTISONE | 5.96e-05 | 5 | 35 | 2 | M47522 | |
| Pathway | REACTOME_METABOLIC_DISORDERS_OF_BIOLOGICAL_OXIDATION_ENZYMES | 7.96e-05 | 34 | 35 | 3 | M27461 | |
| Pathway | WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES | 1.58e-04 | 111 | 35 | 4 | M48065 | |
| Pathway | WP_OXIDATION_BY_CYTOCHROME_P450 | 1.62e-04 | 43 | 35 | 3 | MM15873 | |
| Pathway | REACTOME_METABOLISM_OF_STEROIDS | 2.57e-04 | 126 | 35 | 4 | MM15553 | |
| Pathway | REACTOME_GLUCOCORTICOID_BIOSYNTHESIS | 2.66e-04 | 10 | 35 | 2 | M27076 | |
| Pathway | REACTOME_GLUCOCORTICOID_BIOSYNTHESIS | 3.25e-04 | 11 | 35 | 2 | MM14750 | |
| Pathway | WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY | 3.89e-04 | 12 | 35 | 2 | M45558 | |
| Pathway | REACTOME_MINERALOCORTICOID_BIOSYNTHESIS | 3.89e-04 | 12 | 35 | 2 | MM14749 | |
| Pathway | WP_OXIDATION_BY_CYTOCHROME_P450 | 4.80e-04 | 62 | 35 | 3 | M39653 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 5.27e-04 | 64 | 35 | 3 | M5650 | |
| Pathway | WP_GLUCOCORTICOID_BIOSYNTHESIS | 5.35e-04 | 14 | 35 | 2 | M46449 | |
| Pathway | WP_MINERALOCORTICOID_BIOSYNTHESIS | 5.35e-04 | 14 | 35 | 2 | M46453 | |
| Pathway | REACTOME_METABOLISM_OF_STEROIDS | 5.51e-04 | 154 | 35 | 4 | M27832 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 5.76e-04 | 66 | 35 | 3 | MM14839 | |
| Pathway | WP_ID_SIGNALING | 7.03e-04 | 16 | 35 | 2 | M39359 | |
| Pathway | WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM | 7.03e-04 | 16 | 35 | 2 | M39815 | |
| Pathway | WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS | 1.47e-03 | 23 | 35 | 2 | M39862 | |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | 1.61e-03 | 94 | 35 | 3 | MM15598 | |
| Pathway | REACTOME_ENDOGENOUS_STEROLS | 1.73e-03 | 25 | 35 | 2 | M11184 | |
| Pathway | REACTOME_ENDOGENOUS_STEROLS | 2.02e-03 | 27 | 35 | 2 | MM14844 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 2.15e-03 | 104 | 35 | 3 | M738 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 2.21e-03 | 105 | 35 | 3 | MM14842 | |
| Pubmed | 2.05e-08 | 4 | 61 | 3 | 20660156 | ||
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 5.12e-08 | 5 | 61 | 3 | 12629516 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 6.84e-07 | 94 | 61 | 5 | 21542922 | |
| Pubmed | 1.12e-06 | 12 | 61 | 3 | 14557543 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 17651452 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 23150505 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 34743356 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 35012455 | ||
| Pubmed | Role of genetic variation in regulation of aldosterone biosynthesis. | 3.03e-06 | 2 | 61 | 2 | 21164264 | |
| Pubmed | Polymorphisms in CYP11B2 and CYP11B1 genes associated with primary hyperaldosteronism. | 3.03e-06 | 2 | 61 | 2 | 20339375 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 20808686 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 8645611 | ||
| Pubmed | Expression and localization of cytochrome P450(11beta,aldo) mRNA in the frog brain. | 3.03e-06 | 2 | 61 | 2 | 12231255 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 20634641 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 1303253 | ||
| Pubmed | Aldosterone decreases glucose-stimulated insulin secretion in vivo in mice and in murine islets. | 3.03e-06 | 2 | 61 | 2 | 21519965 | |
| Pubmed | Diagnosis of glucocorticoid-remediable aldosteronism in hypertensive children. | 3.03e-06 | 2 | 61 | 2 | 21625068 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 16110193 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 26066897 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 9060628 | ||
| Pubmed | Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses. | 3.03e-06 | 2 | 61 | 2 | 9460924 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 1741400 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 32540969 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 26047574 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 26324851 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 18651133 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 7669222 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 22083159 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 22933298 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 2783417 | ||
| Pubmed | Cloning and expression of a cDNA for human cytochrome P-450aldo as related to primary aldosteronism. | 3.03e-06 | 2 | 61 | 2 | 2256920 | |
| Pubmed | Editorial: polymorphisms in CYP11B genes and 11-hydroxylase activity. | 3.03e-06 | 2 | 61 | 2 | 15699546 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 18162527 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 38341019 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 20708777 | ||
| Pubmed | Molecular genetic studies on the biosynthesis of aldosterone in humans. | 3.03e-06 | 2 | 61 | 2 | 22217843 | |
| Pubmed | Mechanistic study of polychlorinated biphenyl 126-induced CYP11B1 and CYP11B2 up-regulation. | 3.03e-06 | 2 | 61 | 2 | 16396990 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 24837548 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 30046010 | ||
| Pubmed | Familial and phenotypic associations of the aldosterone Renin ratio. | 3.03e-06 | 2 | 61 | 2 | 19820005 | |
| Pubmed | [123 I]Iodometomidate for molecular imaging of adrenocortical cytochrome P450 family 11B enzymes. | 3.03e-06 | 2 | 61 | 2 | 18397978 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 1518866 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 22622494 | ||
| Pubmed | Mutation analysis of CYP11B1 and CYP11B2 in patients with increased 18-hydroxycortisol production. | 3.03e-06 | 2 | 61 | 2 | 15062555 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 23761669 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 17075030 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 17075029 | ||
| Pubmed | Characterization of two genes encoding human steroid 11 beta-hydroxylase (P-450(11) beta). | 3.03e-06 | 2 | 61 | 2 | 2592361 | |
| Pubmed | CYP11B2-CYP11B1 haplotypes associated with decreased 11 beta-hydroxylase activity. | 3.03e-06 | 2 | 61 | 2 | 15507509 | |
| Pubmed | Polymorphism of CYP11B2 determines salt sensitivity in Japanese. | 3.03e-06 | 2 | 61 | 2 | 17296872 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 23314847 | ||
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 17980006 | ||
| Pubmed | Association between aldosterone production and variation in the 11beta-hydroxylase (CYP11B1) gene. | 3.03e-06 | 2 | 61 | 2 | 16984984 | |
| Pubmed | Evidence for local aldosterone synthesis in the large intestine of the mouse. | 3.03e-06 | 2 | 61 | 2 | 35288482 | |
| Pubmed | Homeostatic responses in the adrenal cortex to the absence of aldosterone in mice. | 3.03e-06 | 2 | 61 | 2 | 15731365 | |
| Pubmed | Salt-sensitive blood pressure in mice with increased expression of aldosterone synthase. | 3.03e-06 | 2 | 61 | 2 | 18039983 | |
| Pubmed | Cyp11b1 null mouse, a model of congenital adrenal hyperplasia. | 3.03e-06 | 2 | 61 | 2 | 19029289 | |
| Pubmed | 3.03e-06 | 2 | 61 | 2 | 15522937 | ||
| Pubmed | 4.88e-06 | 19 | 61 | 3 | 17507402 | ||
| Pubmed | Crumbs2 promotes cell ingression during the epithelial-to-mesenchymal transition at gastrulation. | 7.72e-06 | 22 | 61 | 3 | 27870829 | |
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 8479753 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 36861295 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 18261459 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 21659656 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 19064715 | ||
| Pubmed | Activation of PKC induces leukocyte adhesion by the dephosphorylation of ERM. | 9.07e-06 | 3 | 61 | 2 | 31843195 | |
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 36778748 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 21864676 | ||
| Pubmed | Neurosteroid biosynthesis: genes for adrenal steroidogenic enzymes are expressed in the brain. | 9.07e-06 | 3 | 61 | 2 | 8111631 | |
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 2546938 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 16118390 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 14613898 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 21278069 | ||
| Pubmed | Inhibition of cell adhesion by phosphorylated Ezrin/Radixin/Moesin. | 9.07e-06 | 3 | 61 | 2 | 26555866 | |
| Pubmed | Interaction of CYP11B1 (cytochrome P-45011 beta) with CYP11A1 (cytochrome P-450scc) in COS-1 cells. | 9.07e-06 | 3 | 61 | 2 | 10411633 | |
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 18974272 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 17984374 | ||
| Pubmed | Human ezrin-moesin-radixin proteins modulate hepatitis C virus infection. | 9.07e-06 | 3 | 61 | 2 | 23703860 | |
| Pubmed | Different isozymes of mouse 11 beta-hydroxylase produce mineralocorticoids and glucocorticoids. | 9.07e-06 | 3 | 61 | 2 | 1686470 | |
| Pubmed | Pseudomonas aeruginosa ExoS ADP-ribosyltransferase inhibits ERM phosphorylation. | 9.07e-06 | 3 | 61 | 2 | 16889625 | |
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 10516026 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 2233742 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 33271253 | ||
| Pubmed | Mislocalization of protein kinase A drives pathology in Cushing's syndrome. | 9.07e-06 | 3 | 61 | 2 | 35830806 | |
| Pubmed | Nuclear ERM (ezrin, radixin, moesin) proteins: regulation by cell density and nuclear import. | 9.07e-06 | 3 | 61 | 2 | 15149851 | |
| Pubmed | The prolactin regulatory element-binding regulates of the 11beta-hydroxylase gene. | 9.07e-06 | 3 | 61 | 2 | 18801336 | |
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 11932209 | ||
| Pubmed | Effect of knockdown of ezrin, radixin, and moesin on P-glycoprotein function in HepG2 cells. | 9.07e-06 | 3 | 61 | 2 | 21837648 | |
| Pubmed | ERM stable knockdown by siRNA reduced in vitro migration and invasion of human SGC-7901 cells. | 9.07e-06 | 3 | 61 | 2 | 21352885 | |
| Pubmed | Ezrin and moesin function together to promote T cell activation. | 9.07e-06 | 3 | 61 | 2 | 19124745 | |
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 1429901 | ||
| Pubmed | ERM Proteins at the Crossroad of Leukocyte Polarization, Migration and Intercellular Adhesion. | 9.07e-06 | 3 | 61 | 2 | 32098334 | |
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 18295815 | ||
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 21467193 | ||
| Pubmed | Dmoesin controls actin-based cell shape and polarity during Drosophila melanogaster oogenesis. | 9.07e-06 | 3 | 61 | 2 | 12360288 | |
| Pubmed | Activation of Ras requires the ERM-dependent link of actin to the plasma membrane. | 9.07e-06 | 3 | 61 | 2 | 22132106 | |
| Pubmed | Dynamics and function of ERM proteins during cytokinesis in human cells. | 9.07e-06 | 3 | 61 | 2 | 28889652 | |
| Pubmed | Control of adipogenesis by ezrin, radixin and moesin-dependent biomechanics remodeling. | 9.07e-06 | 3 | 61 | 2 | 23116763 | |
| Pubmed | Control of renin secretion from kidneys with renin cell hyperplasia. | 9.07e-06 | 3 | 61 | 2 | 24285498 | |
| Pubmed | 9.07e-06 | 3 | 61 | 2 | 7750493 | ||
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 2.00e-06 | 50 | 33 | 4 | 1293 | |
| GeneFamily | Cytochrome P450 family 11 | 9.68e-06 | 3 | 33 | 2 | 1007 | |
| GeneFamily | Pyrin domain containing|Pyrin and HIN domain family | 9.44e-04 | 25 | 33 | 2 | 994 | |
| GeneFamily | NLR family | 9.44e-04 | 25 | 33 | 2 | 666 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 3.75e-03 | 50 | 33 | 2 | 721 | |
| ToppCell | P15-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.81e-06 | 176 | 56 | 5 | 792f414f5092aba14260b8e16378e793a822498e | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P1-P1_2-Tnr-Polydendrocye.Tnr.Pdgfa_(Pdgfa)|Striatum / BrainAtlas - Mouse McCarroll V32 | 7.13e-06 | 98 | 56 | 4 | 26250ea4171a0557a67505839cf79d3fe4d9d41a | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P1-P1_2-Tnr|Striatum / BrainAtlas - Mouse McCarroll V32 | 7.13e-06 | 98 | 56 | 4 | 42875d16ae9fcbaf988cd71be82568f2f862f2dd | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P1-P1_2|Striatum / BrainAtlas - Mouse McCarroll V32 | 7.13e-06 | 98 | 56 | 4 | 7a62a77ca83153dacff4d02d6e32104227d0980d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.52e-05 | 147 | 56 | 4 | f5109e0f4e8b46a977a763c9c72a2df9840e3977 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.52e-05 | 147 | 56 | 4 | ad0c575bc9c5f201f2a7810452e8b3f741e65d89 | |
| ToppCell | normal_Pleural_Fluid-B_lymphocytes-Plasma_cells|B_lymphocytes / Location, Cell class and cell subclass | 4.12e-05 | 153 | 56 | 4 | a156710217ef07c07a80ca6504fa0784d86380fa | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.49e-05 | 172 | 56 | 4 | d65ffff3e341af34a043a0d802d7ba4b69de36e9 | |
| ToppCell | 10x_5'_v1-Neoplastic-Stem-like-OPC-like|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.94e-05 | 175 | 56 | 4 | cc596907ea1a64ab7b5a8c7d4ad12e6ee59bfed9 | |
| ToppCell | 10x_5'_v1-Neoplastic-Stem-like|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.94e-05 | 175 | 56 | 4 | a8400e7e47379901dcab5f2e364c3ff17765b4b9 | |
| ToppCell | 10x_5'_v1-Neoplastic-Stem-like-OPC-like-OPC-like|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.94e-05 | 175 | 56 | 4 | 8a3abf40146ae3459d97cdf865c1c8f6b92ac639 | |
| ToppCell | 10x_5'_v1-Neoplastic-Stem-like-OPC-like-OPC-like-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.94e-05 | 175 | 56 | 4 | 378d2b79edac91fc74eee0fb42bb29dd9b07c36f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.25e-05 | 183 | 56 | 4 | b5ede5a0048c585b73c00e88aeddbcaf669347b1 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.25e-05 | 183 | 56 | 4 | 3ef9ac1ae13b6172f9121ab1c129ecaa0fef460f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.96e-05 | 187 | 56 | 4 | f6217d0dd425eac76900b44a4e48f45475f3ac36 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.96e-05 | 187 | 56 | 4 | e3095455d2f255854f339f6b05fa87852af0700f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.15e-05 | 188 | 56 | 4 | e30a4ddac0da8cdcf621d98e28e3895cd9307e7a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.34e-05 | 189 | 56 | 4 | 3a295c215b5c18e7c673f92b7af5be523421682c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.53e-05 | 190 | 56 | 4 | b7f8c2bb9459f1d7c1690069dd5a25a81a57cc84 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.53e-05 | 190 | 56 | 4 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.92e-05 | 192 | 56 | 4 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | COVID-19-kidney-CD-PC|kidney / Disease (COVID-19 only), tissue and cell type | 1.01e-04 | 193 | 56 | 4 | 738689d009e4b118d7ce3171a207294b95cbe78b | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.03e-04 | 194 | 56 | 4 | 88db9f9e80c20ff3474f1f6459dcbdc25aec0b6d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.03e-04 | 194 | 56 | 4 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.03e-04 | 194 | 56 | 4 | a71728202493d4858342ea2756ea281cd0d99a3a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-04 | 194 | 56 | 4 | 45708cb2cafde10bf4e4798b81d47c3b1f6aaa14 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-04 | 195 | 56 | 4 | 247803cf58c6d9c561a52aa34e581188ddad197e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.05e-04 | 195 | 56 | 4 | 562e4c0e4e81f6303e57b846da71d1667fc35963 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.05e-04 | 195 | 56 | 4 | fa8ac154e5aebc26463ff84f0ad1038095770bc6 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.14e-04 | 199 | 56 | 4 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| Drug | cyadox | 6.16e-06 | 2 | 57 | 2 | ctd:C020728 | |
| Drug | 18-hydroxydeoxycorticosterone | 6.16e-06 | 2 | 57 | 2 | ctd:C042509 | |
| Drug | 18-hydroxycortisol | 1.84e-05 | 3 | 57 | 2 | ctd:C033689 | |
| Disease | adrenal cortical adenoma (is_marker_for) | 3.29e-06 | 2 | 54 | 2 | DOID:0050891 (is_marker_for) | |
| Disease | Glucocorticoid-remediable aldosteronism | 3.29e-06 | 2 | 54 | 2 | C1260386 | |
| Disease | thrombopoietin receptor measurement | 9.85e-06 | 3 | 54 | 2 | EFO_0020769 | |
| Disease | congenital adrenal hyperplasia (implicated_via_orthology) | 9.85e-06 | 3 | 54 | 2 | DOID:0050811 (implicated_via_orthology) | |
| Disease | primary hyperaldosteronism (is_implicated_in) | 3.28e-05 | 5 | 54 | 2 | DOID:446 (is_implicated_in) | |
| Disease | programmed cell death protein 5 measurement | 3.28e-05 | 5 | 54 | 2 | EFO_0801927 | |
| Disease | Conn Syndrome | 4.91e-05 | 6 | 54 | 2 | C1384514 | |
| Disease | Hyperaldosteronism | 4.91e-05 | 6 | 54 | 2 | C0020428 | |
| Disease | protocadherin alpha-7 measurement | 6.86e-05 | 7 | 54 | 2 | EFO_0801973 | |
| Disease | hepatitis C virus infection, cirrhosis of liver | 6.86e-05 | 7 | 54 | 2 | EFO_0001422, EFO_0003047 | |
| Disease | protein FAM163B measurement | 1.17e-04 | 9 | 54 | 2 | EFO_0802936 | |
| Disease | androstenedione measurement | 1.47e-04 | 10 | 54 | 2 | EFO_0007972 | |
| Disease | 3-hydroxyanthranilate 3,4-dioxygenase measurement | 1.79e-04 | 11 | 54 | 2 | EFO_0021862 | |
| Disease | cell growth regulator with EF hand domain protein 1 measurement | 1.79e-04 | 11 | 54 | 2 | EFO_0801461 | |
| Disease | Pulmonary Thromboembolisms | 2.14e-04 | 12 | 54 | 2 | C0524702 | |
| Disease | Pulmonary Embolism | 2.14e-04 | 12 | 54 | 2 | C0034065 | |
| Disease | behavioural inhibitory control measurement | 3.88e-04 | 16 | 54 | 2 | EFO_0008467 | |
| Disease | vision disorder | 3.88e-04 | 16 | 54 | 2 | MONDO_0021084 | |
| Disease | glioma | 7.42e-04 | 22 | 54 | 2 | EFO_0005543 | |
| Disease | Hereditary Paraganglioma-Pheochromocytoma Syndrome | 8.11e-04 | 23 | 54 | 2 | C1708353 | |
| Disease | apolipoprotein L1 measurement | 9.60e-04 | 25 | 54 | 2 | EFO_0021854 | |
| Disease | Beta blocking agent use measurement | 1.21e-03 | 114 | 54 | 3 | EFO_0009929 | |
| Disease | brain infarction (biomarker_via_orthology) | 1.67e-03 | 33 | 54 | 2 | DOID:3454 (biomarker_via_orthology) | |
| Disease | hypertension (implicated_via_orthology) | 1.68e-03 | 128 | 54 | 3 | DOID:10763 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MGDRLMSLEHRFQLQ | 536 | O71037 | |
| MGDRLMSLEHRFQLQ | 536 | Q902F8 | |
| LVRQCNEGAHRMERM | 461 | Q5VV41 | |
| CRLRDLLDIANGHMM | 651 | Q6ZPD9 | |
| MAHLLGSQACMESLR | 1 | Q569K6 | |
| LMGRMEIEACLGSLH | 1166 | Q8IWY9 | |
| EDNLPMFHRCGIMAL | 586 | Q14156 | |
| LHCQERANELMRAMK | 471 | Q33E94 | |
| CRRLVEDGMHALGAM | 366 | Q7L1V2 | |
| LALCMGNHELYMRRR | 281 | P35241 | |
| MDMLLGLDMLRRHQC | 326 | Q8WTU0 | |
| LMMSEVDRCGDNEHL | 396 | Q5VWQ8 | |
| MQELDMLAGLRRSHA | 556 | Q9NSA2 | |
| HRDLAARNCMLRDDM | 721 | Q12866 | |
| QARDRLDCVHMLLQM | 181 | Q8NI38 | |
| FHMDCQDLMAQLRLD | 971 | Q5JYT7 | |
| RKDLLLHMQELCEGM | 676 | Q14164 | |
| MLEHGGLMRDVNRRL | 46 | A6NKD9 | |
| DLGNMHRANVIRLMD | 96 | Q9H2K0 | |
| HRDRVIGLMMTACDL | 651 | Q9Y233 | |
| LALCMGNHELYMRRR | 281 | P26038 | |
| GMLMDGLKELNLHRC | 401 | P22413 | |
| MGDRLMSLEHRFQLQ | 1296 | P63135 | |
| MLLRMSEHRNEALGN | 1 | Q6MZN7 | |
| RERKRMHDLNLAMDG | 91 | Q7RTU3 | |
| LGLLMMTEGRRCQVH | 11 | Q9P2Q2 | |
| CVARNKMGDDLILMH | 2016 | Q6WRI0 | |
| GMMLLSDAHQCRRLY | 151 | Q9H0H3 | |
| MGDRLMSLEHRFQLQ | 536 | P61570 | |
| MGDRLMSLEHRFQLQ | 536 | Q69384 | |
| RHCLGEHLARMEMFL | 446 | Q6VVX0 | |
| GSHAMMDLLVELCLQ | 81 | O75128 | |
| LGMFEMHCEELIRAL | 546 | Q8WXX0 | |
| GMRQCLGRRLAEAEM | 446 | P15538 | |
| LLMSSMDDLIRHCNG | 271 | Q9GZT9 | |
| GMRQCLGRRLAEAEM | 446 | P19099 | |
| MGDRLMSLEHRFQLQ | 536 | Q902F9 | |
| ILRHLDKEVGRCMML | 566 | Q5TBA9 | |
| HRGLCRAFMDLTLMA | 2591 | Q8TDX9 | |
| DMRQGRTLLHCMAGV | 96 | Q9H596 | |
| LCHLLGMNVMEFTRA | 381 | P35580 | |
| EFMDAVCMQLVGRHL | 311 | Q8N465 | |
| RNCMSMGALKDLLRH | 386 | Q5VWM6 | |
| ISDLVRCMRLQRHGM | 2436 | Q12923 | |
| GLAHMIMECDRLFEV | 856 | Q9Y3M8 | |
| GSMRARMLEAHCLLP | 621 | Q8N103 | |
| RRLHGMDMSVLLEQD | 481 | P28749 | |
| KHQMLCDMARISELR | 101 | Q9BSH3 | |
| LQHCMELTDLMRNHL | 406 | Q9NWS8 | |
| RLLHDCQQMLMRLGG | 1126 | P36956 | |
| MRLLQRRGDCFAFMH | 431 | Q7RTR0 | |
| RDARMRLMKHDVNLG | 1136 | Q6P2Q9 | |
| IACLMDMNALLDRFH | 21 | Q5SV17 | |
| LHELQDRNMECLGML | 326 | O60296 | |
| RIHRAMGLAALEVMQ | 526 | Q8NBP0 | |
| VGDERMQCLMRHLAQ | 251 | Q7RTX1 | |
| AMARHLCTILGDMLV | 441 | Q8N3E9 | |
| CGARMMRRLLAQHAT | 171 | Q9BUZ4 | |
| GMLALEMLGRRAHND | 1671 | A7E2V4 | |
| QDMEGDSHRIHRLCM | 1066 | Q5JPB2 | |
| RELSMECGLNNRIRM | 46 | P49815 | |
| GMMLLCEGLRHPQCR | 786 | P59046 |